Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-06-19
2007-06-19
Davis, Ruth A (Department: 1651)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S093460, C424S600000, C424S617000, C435S252500
Reexamination Certificate
active
10978726
ABSTRACT:
The invention describes therapeutic compositions including a lactic acid-producing bacteria, such as isolatedBacillus coagulans, in combination with a bifidogenic oligosaccharides or other cholesterol-reducing agents for use in reducing LDL cholesterol and serum triglycerides. Also described are therapeutic methods using the compositions and systems containing the therapeutic compositions.
REFERENCES:
patent: 4110477 (1978-08-01), Naruse et al.
patent: 4323651 (1982-04-01), Long et al.
patent: 4980180 (1990-12-01), Cully et al.
patent: 5079164 (1992-01-01), Kirkovits et al.
patent: 5102800 (1992-04-01), Hirikoshi et al.
patent: 5176911 (1993-01-01), Tosi et al.
patent: 5200336 (1993-04-01), Kong et al.
patent: 5427777 (1995-06-01), St. Pierre et al.
patent: 5531989 (1996-07-01), Paul
patent: 5607669 (1997-03-01), Mandeville, III et al.
patent: 6811786 (2004-11-01), Farmer et al.
patent: 2001/0006644 (2001-07-01), Bova et al.
patent: 0307158 (1989-03-01), None
patent: 0457539 (1991-11-01), None
patent: 62061572 (1987-03-01), None
patent: WO 93/14187 (1993-07-01), None
patent: WO 94/11492 (1994-05-01), None
Baker et al., “Growth Requirements of 94 Strains ofThermophilic bacilli,” CA. J. Microbiol., 6:557-563, 1960.
Bergey's Manual of Systemic Bacteriology, vol. 2, Sneath, P.H.A. et al., eds., Williams & Wilkens, Baltimore, MD, 1986.
Elmer et al., “A Neglected Modality for the Treatment and Prevention of Selected Intestinal and Vaginal Infections,” JAMA, 275: 870-876, 1996.
Gorbach, “Lactic Acid Bacteria and Human Health,” Ann. Med., 22:37-41, 1990.
Lidbeck et al., “Lactobacilli, anticarcinogenic activities and human intestinal microflora,” Eur. J. Cancer Prev. 1:341-353, 1992.
Malin et al., “Promotion of IgA Immune Response in Patients with Crohn's Disease by Oral Bacteriotherapy withLactobacillusGG,” Ann. Nutr. Metab., 40:137-145,1996.
Mohan et al., “Preliminary Observations on Effect ofLactobacillus sporogeneson Serum Lipid Levels in Hypercholesterolemin Patients,” The Indian Journal of Medical Research, 92; 431-432, 1990.
Molin et al., “Effect of Fermented Oatmeal Soup on te Cholesterol Level andLactobacillusColonization of Rat Intestinal Mucosa,” Antonie Van Leeuwenhoek, 61(3); 167-173, 1992.
Mitsuoka et al., “Effects ofFructo-oligosaccharideson Blood Glucose and Serum Lipids in Diabetic Subjects,” Nutrition Research, 4:961-966, 1984.
Nakamura et al., “Taxonomic Study ofBacillus coagululansHammer 1915 with a Proposal forBacillus smithiisp. nov.,” Int. J. Syst. Bacteriol., 38:63-73, 1988.
Perdigon et al., “Symposium: Probiotic Bacteria for Humans: Clinical Systems for Evaluation of Effectiveness,” J. Dairy Sci., 78:1597-1606,1995.
Rafter et al., “The Role of Lactic Acid Bacteria in Colon Cancer Prevention,” Scand. J. Gastroenterol., 80:497-502, 1995.
Reid et al., “Is there a Role forLactobacilliin Prevention of Urogenital and Intestinal Infections?” Clin. Microbiol. Rev., 335-344, 1990.
Salimen et al., “Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges,” Antonie Van Leeuwenhoek, 70(2-4): 347-358, 1996.
Schaafsma et al., “Effects of a Milk Product, Fermented byLactobacillus acidophilusand WithFructo-ogliosaccharidesAdded, on Blood Lipids in Male Vlounteers,” European Journal of Clinical Nutrition, 52(6); 436-440, 1998.
Winberg et al., “Pathogenesis of urinary tract infection- experimental studies of vaginal resistance to colonization,” Pediatr. Nephrol., 7:509-514, 1993.
Fukushima et al., “The effect of a probiotic on faecal and liver lipid classes in rats”,Br. J. Nutr.,73(5):701-710 (1995).
Farmer Scan
Lefkowitz Andrew R.
Beattie Ingrid A.
Davis Ruth A
Ganeden Biotech, Inc.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Methods for reducing cholesterol using Bacillus coagulans... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for reducing cholesterol using Bacillus coagulans..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing cholesterol using Bacillus coagulans... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3844738